Endothelial dysfunction and stomach cancer: from knowledge to action
Gastric cancer (GC) remains one of the most prevalent malignancies worldwide, with a high mortality rate. Among the many pathophysiological mechanisms involved, endothelial dysfunction (ED) has recently been identified as a key factor in tumour progression, angiogenesis, and postoperative complications. This review summarises the current knowledge regarding the role of ED in the pathogenesis of GC, including its impact on the tumour microenvironment, inflammatory processes, metabolic reprogramming and resistance to therapy. Particular attention is paid to molecular markers of ED, such as nitric oxide (NO), von Willebrand factor (vWF) and circulating endothelial cells (CECs), and their prognostic and diagnostic significance. The impact of surgical intervention and chemotherapy on endothelial integrity is also considered. Additionally, the interrelationship between Helicobacter pylori infection, chronic inflammation, and ED is explored. We believe that targeting ED therapeutically may represent a promising approach to improving outcomes in patients with GC.
Сведения
- Опубликовано
- 2025 · № 3, С. 112-124
- Язык
- Английский
- ISSN
- 0514-2415
- Издатель
- МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОЙ ЗАЩИТЫ НАСЕЛЕНИЯ РЕСПУБЛИКИ ТАДЖИКИСТАН
- Аффилиации
- Almaty regional multidisciplinary clinic
Peoples’ Friendship University of Russia named after Patrice Lumumba
SEI Avicenna Tajik State University